Financial News
Articles published by Novocure
![](https://mms.businesswire.com/media/20230721571833/en/721126/5/novocure_main%405x.jpg)
![](https://mms.businesswire.com/media/20230703250896/en/721126/5/novocure_main%405x.jpg)
Novocure to Report Second Quarter 2023 Financial Results
July 03, 2023
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20230601006070/en/721126/5/novocure_main%405x.jpg)
![](https://mms.businesswire.com/media/20230531006041/en/721126/5/novocure_main%405x.jpg)
Novocure Pledges $3 Million to Conquer Cancer®, the ASCO Foundation, to Support Cancer Research and Education
June 01, 2023
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20230504005282/en/721126/5/novocure_main%405x.jpg)
![](https://mms.businesswire.com/media/20230426005597/en/721126/5/novocure_main%405x.jpg)
![](https://mms.businesswire.com/media/20230413005882/en/721126/5/novocure_main%405x.jpg)
![](https://mms.businesswire.com/media/20230403005046/en/721126/5/novocure_main%405x.jpg)
Novocure to Report First Quarter 2023 Financial Results
April 03, 2023
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20230329005240/en/721126/5/novocure_main%405x.jpg)
Kristin Stafford Joins Novocure Board of Directors
March 29, 2023
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20230316005240/en/721126/5/novocure_main%405x.jpg)
Novocure Announces 5th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
March 16, 2023
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20230301005452/en/721126/5/novocure_main%405x.jpg)
Novocure Announces Reimbursement of Optune® for the Treatment of Newly Diagnosed Glioblastoma in France
March 01, 2023
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20230301005321/en/721126/5/novocure_main%405x.jpg)
![](https://mms.businesswire.com/media/20230223005536/en/721126/5/novocure_main%405x.jpg)
Novocure Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update
February 23, 2023
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20230223005180/en/721126/5/novocure_main%405x.jpg)
Allyson J. Ocean, M.D., Joins Novocure Board of Directors
February 23, 2023
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20230215005254/en/721126/5/novocure_main%405x.jpg)
Novocure Announces Last Patient Enrolled in Pivotal PANOVA-3 Study of Tumor Treating Fields in Pancreatic Cancer
February 15, 2023
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20230119005132/en/721126/5/novocure_main%405x.jpg)
![](https://mms.businesswire.com/media/20230109005138/en/721126/5/novocure_main%405x.jpg)
Novocure Announces Preliminary Full Year and Fourth Quarter 2022 Net Revenues and Provides Company Update
January 09, 2023
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20230105005325/en/721126/5/novocure_main%405x.jpg)
Novocure Announces Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint
January 05, 2023
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20221227005008/en/721126/5/novocure_main%405x.jpg)
Novocure to Participate in 41st Annual J.P. Morgan Healthcare Conference
December 27, 2022
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20221129005033/en/721126/5/novocure_main%405x.jpg)
Novocure’s Optune® Approved in Canada for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
November 29, 2022
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20221123005006/en/721126/5/novocure_main%405x.jpg)
![](https://mms.businesswire.com/media/20221117005144/en/721126/5/novocure_main%405x.jpg)
Novocure Announces 25 Abstracts on Tumor Treating Fields Therapy at Society for Neuro-Oncology 2022 Annual Meeting
November 17, 2022
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20221115005460/en/1637032/5/Canada_office_opening.jpg)
Novocure Opens Office in Montreal to Expand and Support Growing Business in Canada
November 15, 2022
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20221111005113/en/721126/5/novocure_main%405x.jpg)
Novocure Secures CE Mark for New Array
November 11, 2022
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20221027005570/en/721126/5/novocure_main%405x.jpg)
Novocure Reports Third Quarter 2022 Financial Results
October 27, 2022
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20221021005493/en/721126/5/novocure_main%405x.jpg)
![](https://mms.businesswire.com/media/20221020005705/en/721126/5/novocure_main%405x.jpg)
![](https://mms.businesswire.com/media/20221020005708/en/721126/5/novocure_main%405x.jpg)
Novocure Launches Campaign to Drive Awareness and Understanding of Tumor Treating Fields Therapy
October 20, 2022
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20221003005548/en/721126/5/novocure_main%405x.jpg)
Novocure to Report Third Quarter 2022 Financial Results
October 03, 2022
From Novocure
Via Business Wire
Tickers
NVCR
![](https://mms.businesswire.com/media/20220921005432/en/721126/5/novocure_main%405x.jpg)
Novocure Announces Creation of U.S. CNS Cancers Franchise Intended to Renew Focus on Growth in Glioblastoma Business
September 21, 2022
From Novocure
Via Business Wire
Tickers
NVCR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.